Related Experiment Video
Updated: Jul 14, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease
Adriana M Hung1,2, Victoria A Assimon3, Hua-Chang Chen1,4
1Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.
A newly identified APOL1 variant, p.N264K, significantly reduces the risk of chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in individuals with high-risk APOL1 genotypes. This protective effect offers potential therapeutic targets for APOL1-associated kidney disease.
Area of Science:
- Genetics
- Nephrology
- Pharmacology
Background:
- African Americans have a disproportionately high risk of chronic kidney disease (CKD), partly due to high-risk (HR) variants in the apolipoprotein L1 (APOL1) gene.
- The APOL1 gene plays a crucial role in kidney disease susceptibility, particularly in individuals of African ancestry.
Purpose of the Study:
- To investigate the protective effect of a specific APOL1 variant, p.N264K, against CKD and end-stage kidney disease (ESKD) in individuals carrying APOL1 HR genotypes.
- To explore the functional mechanisms by which APOL1 p.N264K mitigates the risk associated with APOL1 HR variants.
Main Methods:
- A large-scale cross-sectional analysis of 121,492 participants of African ancestry from the Million Veteran Program (MVP), with replication in two additional cohorts.
- Analysis compared the association between APOL1 HR genotypes with and without the p.N264K variant, assessing CKD and ESKD as primary and secondary outcomes.
- Functional studies in cell models were conducted to elucidate the molecular mechanisms of APOL1 p.N264K action.
Main Results:
- In the MVP cohort, APOL1 HR genotypes without p.N264K were associated with significantly increased odds of CKD and ESKD.
- The presence of APOL1 p.N264K markedly mitigated the kidney disease risk associated with APOL1 HR variants, lowering it to levels comparable with low-risk genotypes.
- Replication cohorts confirmed that APOL1 p.N264K significantly reduced the renal risk in carriers of APOL1 HR variants.
Conclusions:
- The APOL1 p.N264K variant acts as a protective factor against CKD and ESKD in individuals with APOL1 HR genotypes.
- APOL1 p.N264K functions by blocking the pore-forming activity and ion channel conduction of APOL1, thereby reducing cellular toxicity.
- These findings suggest that mimicking the protective mechanism of APOL1 p.N264K could lead to novel therapeutic strategies for APOL1-associated kidney diseases.
Related Concept Videos
Nephrons
Acute Kidney Injury II: Pathophysiology
Aquaporins
The Intrinsic Apoptotic Pathway
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Abnormal Proliferation

